Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Chegou, Novel N ^a   Essone, Paulin N ^a   Loxton, Andre G ^a   Stanley, Kim ^a   Black, Gillian F ^a   van der Spuy, Gian D ^a   van Helden, Paul D ^a   Franken, Kees L ^b   Parida, Shreemanta K ^c   Klein, Michel R ^b   Kaufmann, Stefan H E ^c   Ottenhoff, Tom H M ^b   Walzl, Gerhard ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P40; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BIOLOGICAL MARKER; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; INTERLEUKIN 12;

ADULT; ARTICLE; BLOOD CULTURE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDEMIC DISEASE; FEMALE; HUMAN; IMMUNOSTIMULATION; INCIDENCE; LUNG TUBERCULOSIS; MALE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; ADOLESCENT; BLOOD; IMMUNOASSAY; IMMUNOLOGY; MIDDLE AGED; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOASSAY; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MIDDLE AGED; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84861872586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038501     Document Type: Article

References (51)

1. Chegou NN, Hoek KG, Kriel M, Warren RM, Victor TC, et al. (2011) Tuberculosis assays: past, present and future. Expert Rev Anti Infect Ther 9: 457-469.
2. Trebucq A, Enarson DA, Chiang CY, Van DA, Harries AD, et al. (2011) Xpert((R)) MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? Int J Tuberc Lung Dis 15: 1567-1572.
3. Chegou NN, Walzl G, Bolliger CT, Diacon AH, van den Heuvel MM, (2008) Evaluation of adapted whole-blood interferon-gamma release assays for the diagnosis of pleural tuberculosis. Respiration 76: 131-138.
4. Munk ME, Arend SM, Brock I, Ottenhoff TH, Andersen P, (2001) Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J Infect Dis 183: 175-176.
5. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, et al. (2011) Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37: 88-99.
6. Hesseling AC, Mandalakas AM, Kirchner HL, Chegou NN, Marais BJ, et al. (2009) Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 64: 840-846.
7. Mandalakas AM, Hesseling AC, Chegou NN, Kirchner HL, Zhu X, et al. (2008) High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 12: 417-423.
8. Dheda K, Smit RZ, Badri M, Pai M, (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200.
9. Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G, (2009) Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 9: 21.
10. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, et al. (2011) Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 17: 372-376.
11. Lighter-Fisher J, Peng CH, Tse DB, (2010) Cytokine responses to QuantiFERON(R) peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis. Int J Tuberc Lung Dis 14: 1548-1555.
12. Lu C, Wu J, Wang H, Wang S, Diao N, et al. (2011) Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS ONE 6: e24290.
13. Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MO, (2010) Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS ONE 5: e12365.
14. Chegou NN, Black GF, Loxton AG, Stanley K, Essone PN, et al. (2012) Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infect Dis 12: 10.
15. Kritzinger FE, den BS, Verver S, Enarson DA, Lombard CJ, et al. (2009) No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health 14: 136-142.
16. Franken KL, Hiemstra HS, van Meijgaarden KE, Subronto Y, den HJ, et al. (2000) Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif 18: 95-99.
17. Black GF, Thiel BA, Ota MO, Parida SK, Adegbola R, et al. (2009) Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol 16: 1203-1212.
18. Schoenborn JR, Wilson CB, (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96: 41-101.
19. Chaisson RE, Martinson NA, (2008) Tuberculosis in Africa-combating an HIV-driven crisis. N Engl J Med 358: 1089-1092.
20. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
21. Frahm M, Goswami ND, Owzar K, Hecker E, Mosher A, et al. (2011) Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 91: 250-256.
22. Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, et al. (2011) Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS ONE 6: e26545.
23. Su WL, Perng WC, Huang CH, Yang CY, Wu CP, et al. (2010) Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia. Clin Vaccine Immunol 17: 771-777.
24. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO, (2009) Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 39: 723-729.
25. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, et al. (2007) CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 9: 806-812.
26. Ruhwald M, Petersen J, Kofoed K, Nakoaka H, Cuevas LE, et al. (2008) Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a diagnostic Test Based on IP-10. Plos One 3: e2858.
27. Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, et al. (2008) Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32: 1607-1615.
28. Tanaka T, Sakurada S, Kano K, Takahashi E, Yasuda K, et al. (2011) Identification of tuberculosis-associated proteins in whole blood supernatant. BMC Infect Dis 11: 71.
29. Rubbo PA, Nagot N, Le Moing V, Brabet M, Bourdin A, et al. (2012) Multi-cytokine detection improves latent tuberculosis diagnosis in healthcare workers. J Clin Microbiol 50: 1711-1717.
30. Jones GJ, Pirson C, Hewinson RG, Vordermeier HM, (2010) Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle. Clin Vaccine Immunol 17: 1946-1951.
31. Ruhwald M, Aabye MG, Ravn P, (2012) IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 12: 175-187.
32. Basu Roy R, Whittaker E, Kampmann B, (2012) Current understanding of the immune response to tuberculosis in children. Curr Opin Infect Dis 25: 250-257.
33. Leyten EM, Lin MY, Franken KL, Friggen AH, Prins C, et al. (2006) Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 8: 2052-2060.
34. Schuck SD, Mueller H, Kunitz F, Neher A, Hoffmann H, et al. (2009) Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection. PLoS ONE 4: e5590.
35. Commandeur S, van Meijgaarden KE, Lin MY, Franken KL, Friggen AH, et al. (2011) Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals. Clin Vaccine Immunol 18: 676-683.
36. Commandeur S, Lin MY, van Meijgaarden KE, Friggen AH, Franken KL, et al. (2011) Double- and monofunctional CD4(+) and CD8(+) T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals. Eur J Immunol 41: 2925-2936.
37. Goletti D, Butera O, Vanini V, Lauria FN, Lange C, et al. (2010) Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J 36: 135-142.
38. Chiacchio T, Petruccioli E, Vanini V, Butera O, Cuzzi G, et al. (2011) Higher Frequency of T-Cell Response to M. tuberculosis Latency Antigen Rv2628 at the Site of Active Tuberculosis Disease than in Peripheral Blood. PLoS ONE 6: e27539.
39. Raja A, (2004) Immunology of tuberculosis. Indian J Med Res 120: 213-232.
40. Ulrichs T, Kaufmann SHE, (2004) Cell-mediated immune response. In: Rom WN, Garay SM, editors. Tuberculosis Lippincott Williams & Wilkins pp. 251-262.
41. Corstjens PL, Chen Z, Zuiderwijk M, Bau HH, Abrams WR, et al. (2007) Rapid assay format for multiplex detection of humoral immune responses to infectious disease pathogens (HIV, HCV, and TB). Ann N Y Acad Sci 1098: 437-445.
42. Corstjens PL, Zuiderwijk M, Tanke HJ, van der Ploeg-van Schip JJ, Ottenhoff TH, et al. (2008) A user-friendly, highly sensitive assay to detect the IFN-gamma secretion by T cells. Clin Biochem 41: 440-444.
43. Corstjens PL, de Dood CJ, van der Ploeg-van Schip JJ, Wiesmeijer KC, Riuttamaki T, et al. (2011) Lateral flow assay for simultaneous detection of cellular- and humoral immune responses. Clin Biochem 44: 1241-1246.
44. Corstjens PL, van LL, Zuiderwijk M, Kornelis D, Tanke HJ, et al. (2008) Up-converting phosphor technology-based lateral flow assay for detection of Schistosoma circulating anodic antigen in serum. J Clin Microbiol 46: 171-176.
45. Feske M, Nudelman RJ, Medina M, Lew J, Singh M, et al. (2008) Enhancement of human antigen-specific memory T-cell responses by interleukin-7 may improve accuracy in diagnosing tuberculosis. Clin Vaccine Immunol 15: 1616-1622.
46. Geluk A, van der Ploeg-van Schip JJ, van Meijgaarden KE, Commandeur S, Drijfhout JW, et al. (2010) Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays. Clin Vaccine Immunol 17: 993-1004.
47. Connell TG, Shey MS, Seldon R, Rangaka MX, van CG, et al. (2007) Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector. Clin Vaccine Immunol 14: 847-854.
48. Palma C, Iona E, Giannoni F, Pardini M, Brunori L, et al. (2008) The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response. Vaccine 26: 4237-4243.
49. Honaker RW, Stewart A, Schittone S, Izzo A, Klein MR, et al. (2008) Mycobacterium bovis BCG vaccine strains lack narK2 and narX induction and exhibit altered phenotypes during dormancy. Infect Immun 76: 2587-2593.
50. Lin MY, Geluk A, Smith SG, Stewart AL, Friggen AH, et al. (2007) Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun 75: 3523-3530.
51. Goin JE, (1982) ROC curve estimation and hypothesis testing: applications to breast cancer detection. Pattern Recognition 15: 263-269.